Uncover key drivers, emerging technologies, and competitive movements shaping the biosimilar testing services market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Market Size Of The Biosimilar Testing Services Industry By 2029?

The biosimilar testing services market has shown rapid expansion in recent years. Its valuation is anticipated to rise from $1.62 billion in 2024 to $1.84 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.3%. This historical growth can be linked to the escalating demand for biologics, the broadening approval of biosimilars, the increasing occurrence of chronic diseases, a growing need for personalized medicine, and the expansion of clinical trial activities.

The biosimilar testing services market is projected to experience substantial expansion in the coming years, reaching $2.99 billion by 2029, driven by a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the rising adoption of biosimilars, a heightened demand for cost-effective treatment options, a greater need for affordable biologic therapies, increasing confidence in the efficacy and safety of biosimilars, and the expanding requirement for tailored testing solutions. Key trends expected over the forecast period encompass progress in analytical testing technologies, ongoing breakthroughs in bioassay development, wider implementation of high-throughput testing platforms, intensified research and development efforts in biosimilar analytics, and the incorporation of artificial intelligence for data analysis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27225&type=smp

Which Growth Drivers Are Shaping The Biosimilar Testing Services Market Outlook?

The increasing incidence of autoimmune conditions is anticipated to drive expansion in the biosimilar testing services market in the future. These diseases occur when the body’s immune system erroneously targets its own healthy cells and tissues, resulting in inflammation and cellular damage. This rise in autoimmune conditions stems from a heightened demand for potent biologic therapies capable of controlling persistent symptoms, minimizing disease exacerbations, and enhancing patient prognosis over time. Biosimilar testing services contribute to autoimmune disease treatment by verifying that biosimilars are secure, efficacious, and equivalent to their reference biologics, thereby facilitating the availability of economical and accessible treatment choices. As an illustration, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government organization, indicated that approximately 514,000 individuals (2.0%) in Australia had rheumatoid arthritis in 2022, impacting 2.5% of females and 1.6% of males. Consequently, the increasing occurrence of autoimmune diseases is a significant factor boosting the biosimilar testing services market.

How Is The Global Biosimilar Testing Services Market Broken Down By Segment?

The biosimilar testing services market covered in this report is segmented

1) By Service Type: Analytical Testing, Bioanalytical Testing, Stability Testing, Method Development And Validation, Other Service Types

2) By Technology: Cell-Based Assays, Chromatography Techniques, Mass Spectrometry, Bioassays

3) By Molecule Type: Monoclonal Antibodies, Recombinant Hormones, Insulin, Interferons, Enzymes, Other Molecule Types

4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Government Agencies

Subsegments:

1) By Analytical Testing: Protein Characterization, Impurity Profiling, Potency Testing, Glycosylation Analysis, Structural Analysis

2) By Bioanalytical Testing: Pharmacokinetics Analysis, Immunogenicity Testing, Biomarker Analysis, Drug Concentration Measurement, Toxicokinetics Testing

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Testing, Photostability Testing, Temperature Cycling Studies

4) By Method Development And Validation: Analytical Method Development, Bioanalytical Method Development, Method Validation, Process Validation, Assay Development

5) By Other Service Types: Immunogenicity Assessment, Formulation Development, Microbial Testing, Release Testing, Regulatory Consulting

Which Trends Are Likely To Redefine Growth Paths In The Biosimilar Testing Services Market?

Leading firms within the biosimilar testing services market are prioritizing facility expansion to incorporate novel technologies or capacities, thereby boosting their efficiency and competitive edge. This involves either enlarging current physical spaces or enhancing existing infrastructure to meet rising operational demands or facilitate prospective development. An illustrative example is that in October 2023, Tanvex BioPharma USA Inc., a biotechnology company situated in the US, unveiled Tanvex CDMO, a modern contract development and manufacturing organization based in San Diego, providing comprehensive biologics development and manufacturing services, which encompass cell line development, process optimization, analytical testing, and regulatory assistance. The objective of this new facility is to expedite the progression of biopharmaceutical products from their initial concept to a commercial production level, utilizing advanced technologies and skilled teams to ensure the global delivery of inventive and transformative biologics to patients.

Who Are The Primary Market Leaders In The Biosimilar Testing Services Market?

Major companies operating in the biosimilar testing services market are Thermo Fisher Scientific Inc., IQVIA Laboratories, Laboratory Corporation of America Holdings, Fresenius SE & Co. KGaA, Eurofins Scientific SE, Intas Pharmaceuticals Ltd., SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Intertek Group plc, Samsung Biologics Co. Ltd., Celltrion Inc., Almac Group Limited, Syngene International Limited, Shanghai Medicilon Inc., Kymos Group S.L., Pacific BioLabs Inc., Profacgen Inc., ExcellGene SA, BioPharmaSpec Ltd., and Sartorius Stedim Biotech Group.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Biosimilar Testing Services Market?

North America was the largest region in the biosimilar testing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilar testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27225&type=smp

Browse Through More Reports Similar to the Global Biosimilar Testing Services Market 2025, By The Business Research Company

Cold Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-insulation-global-market-report

Aircraft Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aircraft-insulation-global-market-report

Technical Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model